Aopia launches NanoEX™ at 2024 ISEV conference

Aopia Biosciences officially launches the NanoEX™ Automated Bio-nanoparticle Isolation Platform on May 12th, 2024 at the 2024 ISEV annual conference, Melbourne, Australia. The NanoEX™ is the next generation platform for isolating bio-nanoparticles, such as extracellular vesicles (EV), lipid nanoparticles (LNP), and gene therapy vectors. The system uses a patent-pending Asymmetric Nanopore Membrane (ANM) technology to […]

Aopia secures seed round investment

Aopia Biosciences secured seed round of investment to support the development and commercialization of NanoEX™, a next-generation extracellular vesicle (EV) isolation and enrichment platform. NanoEX™ is based on the patented asymmetric nanopore membrane (ANM) technology and can deliver unparalleled EV isolation efficiency and purity. This highly scalable platform not only allows fast purification of exosomes […]